Denosumab Suppliers & Bulk Manufacturers

Available Forms: Subcutaneous injection

Available Strengths: subcutaneous injection

Reference Brands: Xgeva; Wyost - biosimilar to Xgeva

Category: Biosimilars

Denosumab is available in Subcutaneous injection and strengths such as subcutaneous injection. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Denosumab is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Denosumab can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description:

Wyost, a biosimilar to Xgeva (denosumab), is regulated in the EU and US with dossiers demonstrating biosimilarity, safety, efficacy, and manufacturing quality in compliance with GMP standards. In the US, FDA approval requires extensive comparability data and validation, while in the EU, CE marking certifies conformity with MDR standards. These biosimilars undergo validation, stability testing, and audits, supported by comprehensive documentation including biosimilarity, clinical trial data, safety profiles, and manufacturing practices. For licensing procedures, approved dossiers, and the latest regulatory updates, visit Pharmatradz. Ensuring compliance guarantees access to affordable, high-quality denosumab biosimilars for osteoporosis and bone metastases treatment worldwide.